By Scott Burris It’s hard to believe that after all these years, all the evidence, and all the reductions in HIV among injection drug users, we still only have 15 states that explicitly authorize syringe exchange programs (SEPs). (See LawAtlas for an interactive map.) CDC estimates we still have around 4,000 new cases a year…
By I. Glenn Cohen As the New York Times reported this week, in an article entitled “Another Use for Rapid Home H.I.V. Test: Screening Sexual Partners,” some in the public health community are exploring the ramifications for a use of the new OraQuick home HIV test that the company has been somewhat coy about: using…
By Scott Burris A law professor is usually thrilled to have an article cited by the Supreme Court. An empirical researcher will, likewise, be pleased that evidence he or she helped create shapes a decision of the highest court of the land. But maybe not always. Today I learned that the Supreme Court cited a…
By Scott Burris The concept of “overcriminalization” is gaining traction across the political spectrum. The Heritage Foundation, which has a website devoted to the phenomenon, defines it as “the trend in America – and particularly in Congress – to use the criminal law to ‘solve’ every problem, punish every mistake (instead of making proper use…
By Adriana Benedict Last week, Public Citizen published a Health GAP analysis entitled “Leaked TPP Investment Chapter Presents a Grave Threat to Access to Medicines,” in which Professor Brook Baker explains four ways in which access to medicines is compromised by the USTR’s leaked investment chapter proposal for the Trans-Pacific Partnership Agreement. The problematic provisions…
By Frank Pasquale Last week, the blog Concurring Opinions featured a symposium on Madhavi Sunder’s new book, From Goods to a Good Life: Intellectual Property and Global Justice. A chapter relevant to health law scholars is available online, here. The chapter focuses on access to drugs in less developed countries (LDCs), and makes the following…
